Brind.
  1. DHI and Becton Dickinson were analyzed in a report concerning their stock performance.

Becton Dickinson's stock performance relative to the S&P 500 was recently reported.

3 reports, 3 independent Updated Aug 17
Gone quiet Reached 2 outlets in its first 24 hours
Reports
3
Developments
2
Repetition
33%

New informationRepeats or wire copies

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Well supportedReported by 3 independent outlets

Becton Dickinson's stock performance relative to the S&P 500 was recently reported.

Who's involved

What this event is mainly about
Becton Dickinson

How it developed

Newest first. Tap a step to see who reported it.
  1. BDX stock performance is affected by international market headwinds, specifically from China.1 source
  2. BDX stock showed mixed performance against S&P 500 over different timeframes.1 source

Keep exploring

Part of

DHI and Becton Dickinson were analyzed in a report concerning their stock performance. All 1 developments

The entities involved

Coverage

Newest first; wire copies grouped
  • yahoo.com
  • BarchartIs Becton, Dickinson and Company Stock Underperforming the S&P 500? With a market cap of $54.8 billion, Becton, Dickinson and Company (BDX) is a global medical technology firm that develops, manufact
  • Simply Wall St.Becton Dickinson (BDX) Unveils Wearable Injector Trial and Declares US$1.04 Quarterly Dividend Becton Dickinson recently announced the initiation of a pharma-sponsored clinical trial featuring their